Department of Otorhinolaryngology and Head and Neck Oncology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.
Department of Otorhinolaryngology and Head and Neck Oncology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.
Oral Oncol. 2018 Sep;84:76-81. doi: 10.1016/j.oraloncology.2018.07.014. Epub 2018 Jul 22.
In shared decision making it is important to adequately, timely and actively involve patients in treatment decisions. Sharing prognostic information can be of key importance. This study describes whether and how prognostic information on life expectancy is included during communication on diagnosis and treatment plans between physicians and head and neck (H&N) oncologic patients in different phases of disease.
A descriptive, qualitative study was performed of n = 23 audiotaped physician-patient conversations in which both palliative and curative treatment options were discussed and questions on prognosis were expected. Verbatim transcribed consultations were systematically analyzed. A distinction was made between prognostic information that was provided (a) quantitatively: by giving numerical probability estimates, such as percentages or years or (b) qualitatively: through the use of words such as 'most likely' or 'highly improbable'.
In all consultations, H&N surgeons provided some prognostic information. In 5.9% of the provided prognostic information, a quantitative method was used. In 94.1% prognostic information was provided qualitatively, using six identified approaches. H&N surgeons possibly affect patients' perception of prognostic content with two identified communication styles: directive (more physician-centered) and affective (more patient-centered).
This study is first in providing examples of how H&N surgeons communicate with their patients regarding prognosis in all stages of disease. They often exclude specific prognostic information. The study outcomes can be used as a first step in developing a guideline for sharing prognostic information in H&N oncologic patients, in order enable the process of shared decision making.
在共同决策中,重要的是充分、及时和积极地让患者参与治疗决策。分享预后信息可能至关重要。本研究描述了在诊断和治疗计划的沟通中,医生与头颈部(H&N)肿瘤患者在疾病的不同阶段,是否以及如何纳入关于预期寿命的预后信息。
这是一项描述性、定性研究,对 23 段记录了姑息和根治治疗方案讨论以及预期预后问题的医患对话进行了录音,并对逐字记录的咨询进行了系统分析。对提供的预后信息进行了区分:(a)定量:通过给出百分比或年等数值概率估计;(b)定性:通过使用“最有可能”或“极不可能”等词语。
在所有的咨询中,H&N 外科医生都提供了一些预后信息。在提供的预后信息中,有 5.9%使用了定量方法,94.1%的预后信息是定性提供的,使用了六种确定的方法。H&N 外科医生可能会通过两种已识别的沟通方式影响患者对预后内容的感知:指令性(更以医生为中心)和情感性(更以患者为中心)。
本研究首次提供了 H&N 外科医生在疾病的所有阶段与患者就预后进行沟通的示例。他们经常排除特定的预后信息。研究结果可以作为制定 H&N 肿瘤患者预后信息共享指南的第一步,以促进共同决策过程。